搜索筛选:
搜索耗时2.9540秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
[期刊论文] 作者：Kaichao Feng,Yelei Guo,Hanren,
来源：中国科学：生命科学英文版 年份：2016
妄想的抗原获得的成功在 hematological 恶意的修改受体的 T (大车) 房间在非小的肺癌症(NSCLC ) 提起了他们的使用的可能性。在这个阶段我临床的学习(NCT01869166 ) ，有表皮...
,Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and cu
[期刊论文] 作者：Yelei Guo,Kaichao Feng,Yao Wang,Weidong Han,
来源：蛋白质与细胞 年份：2018
Cancer stem cells (CSCs),a subpopulation of tumor cells,have self-renewal and multi-lineage differentiation abilities that play an important role in cancer init...
Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing ad
[期刊论文] 作者：Kaichao Feng,Yelei Guo,Hanren Dai,Yao Wang,Xiang Li,Hejin Jia,Weidong Han,,
来源：Science China(Life Sciences) 年份：2016
The successes achieved by chimeric antigen receptor-modified T(CAR-T) cells in hematological malignancies raised the possibility of their use in non-small lung...
,Phase Ⅰ study of chimeric antigen receptor modified T cells in treating HER2-positive advanced bili
[期刊论文] 作者：Kaichao Feng,Yang Liu,Yelei Guo,Jingdan Qiu,Zhiqiang Wu,Hanren Dai,Qingming Yang,Yao Wang,Weidong Han,
来源：蛋白质与细胞 年份：2018
This phase Ⅰ clinical trial (NCT01935843) is to evaluate the safety,feasibility,and activity of chimeric antigen receptor-engineered T cell (CART) immunotherap...
Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of cli
[期刊论文] 作者：Lv,Meixia Chen,Rui Zhang,Wen Zhang,Chenguang Wang,Yan Zhang,Xiaoming Wei,Yukun Guan,Jiejie Liu,Kaichao Feng,
来源：细胞研究（英文版） 年份：2020
CD8+ T cell-mediated cancer clearance is often suppressed by the interaction between inhibitory molecules like PD-1 and PD-L1,an interaction acts like brakes to...
相关搜索：
